Delivery Order 75A50122D00004-75A50124F61009
Award Date
2/22/24
Potential Completion Date
5/21/27
Potential Value
$396K
Awardee
Seqirus Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Holly Springs, NC, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Seqirus Inc., a division of the global biotechnology company CSL Seqirus, is for the provision of medical countermeasures, such as vaccines and adjuvants, for pandemic preparedness and response. The $11.82 million contract, awarded on February 22, 2024, is a Firm Fixed Price Delivery Order issued under Seqirus' $13.4 billion Indefinite Delivery Contract (IDC) with the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for...
This federal contract award to Seqirus Inc., a division of global biotechnology company CSL Seqirus, has a ceiling value of $1,904,213.20. The purpose of the contract is to provide medical countermeasures (MCMs), such as vaccines and adjuvants, for pandemic preparedness and response as required by the Department of Health and Human Services (HHS).
Seqirus operates a manufacturing facility in Holly Springs, North Carolina and is a leading provider of MCMs to the U.S. federal government. The...
This federal contract award was issued by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of CSL Seqirus, a leading global biotechnology company. The $3,765,429.00 Delivery Order was placed under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract, a $13.4 billion IDIQ held by Seqirus with HHS ASPR. The contract is for the Acquisition of Medical...
This is a delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the Department of Health and Human Services (HHS) to Seqirus Inc., a division of CSL Seqirus, a global biotechnology company. The $259,725.00 firm-fixed price award is for the Acquisition of Medical Countermeasures (MCMs) for Pandemic Influenza Preparedness and Response. It is a task order under Seqirus' $13.4 billion Indefinite Delivery Contract with ASPR to provide vaccines,...
This contract award to Seqirus Inc., a division of the global biotechnology company CSL Seqirus, was issued by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The $20,539,764.00 Delivery Order is for the "Acquisition of MCMS for Pandemic Influenza Preparedness and Response" and is part of a larger $13.4 billion Indefinite Delivery Contract (IDC) awarded to Seqirus in February 2022. Under this IDC, ASPR...
This is a delivery order contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of CSL Seqirus. The $935,783.43 firm-fixed-price contract is for the provision of medical countermeasures, including vaccines, adjuvants, and related services, to support pandemic preparedness and response efforts. The work is being performed at Seqirus' facility in Holly Springs, North Carolina. This...
This federal contract award to Seqirus Inc. was issued by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract (IDC). The $402,112 firm fixed-price delivery order is for the acquisition of medical countermeasures (MCMs) for pandemic influenza preparedness and response, including the production, storage, and stability testing of...
This federal contract award was issued by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of the global biotechnology company CSL Seqirus. The contract, valued at $1,134,584.52, is a delivery order under ASPR's Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract (IDC). The contract is for the acquisition of medical countermeasures for pandemic influenza...
This is a $19,471.20 fixed-price level of effort delivery order awarded to Seqirus Inc., a division of CSL Seqirus, by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The order is for the acquisition of medical countermeasures for pandemic influenza preparedness and response, and is placed under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract held by Seqirus with HHS ASPR. This...
This is a federal contract award from the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Seqirus Inc., a division of CSL Seqirus, a leading global biotechnology company. The contract, valued at $34,163.00, is for the continuation of a physical chemical compatibility study of the H7N9 influenza vaccine with the MF59 adjuvant for an additional 18 months. The contract is a firm fixed-price purchase order with no set-aside...